APTUS PHARMA : BSE GRANTS IN-PRINCIPLE APPROVAL FOR PREFERENTIAL ISSUE

• Approval under Regulation 28(1) of SEBI LODR via BSE letter dated October 30, 2026 • Proposed preferential issue of equity shares was approved by shareholders at AGM held September 14, 2026 Impact: Neutral (Procedural clearance only; no issue size, price or allottee details disclosed)

Aptus Pharma Ltd

Open attachment

← Back to feed